Loading insider details...
Beta
Latest Form 4 (Aug 20, 2026): Exercise/Conversion of 3,086 CTKB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Cytek Biosciences, Inc. (CTKB) | Exercise/Conversion | 3,086 | n/a |
| Jun 12, 2026 | Cytek Biosciences, Inc. (CTKB) | Grant/Award | 55,555 | n/a |
| May 29, 2026 | Neuronetics, Inc. (STIM) | Grant/Award | 30,000 | n/a |
| May 18, 2026 | REPLIGEN CORP (RGEN) | Grant/Award | 995 | n/a |
| May 8, 2026 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 2,434 | $94.3K |
| Dec 17, 2025 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 3,366 | $87.9K |
| Oct 22, 2025 | Neuronetics, Inc. (STIM) | Grant/Award | 7,554 | n/a |
| May 27, 2025 | Neuronetics, Inc. (STIM) | Grant/Award | 30,000 | n/a |
| May 20, 2025 | REPLIGEN CORP (RGEN) | Grant/Award | 973 | n/a |
| Feb 10, 2025 | Neuronetics, Inc. (STIM) | Other (see footnotes) | 44,444 | $100.0K |